Physician profile
Bryan L Davidson
NPI 1568628824
$2,170.45
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,781 · 2020: $325 · 2021: $13.00 · 2022: $50.65.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $437.98 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $223.18 | 2019-2020 | |
| Glaxosmithkline, LLC. | $193.95 | 2019 | |
| Janssen Pharmaceuticals, INC | $183.50 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $120.21 | 2019-2020 | |
| Novo Nordisk INC | $111.73 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $82.28 | 2019-2020 | |
| Pfizer INC. | $80.23 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $72.65 | 2019-2020 | |
| Vertiflex, INC. | $71.63 | 2019 | |
| Allergan, INC. | $65.04 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $56.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.22 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.15 | 2019 | |
| Amarin Pharma, INC. | $45.51 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $40.92 | 2019 | |
| Boston Scientific Corporation | $38.25 | 2022 | |
| Therapeuticsmd, INC. | $35.93 | 2019 | |
| Arbor Pharmaceuticals, INC. | $33.60 | 2019 | |
| Horizon Therapeutics Plc | $31.05 | 2019 | |
| Genentech USA, INC. | $24.89 | 2019 | |
| Celgene Corporation | $22.19 | 2019 | |
| Ironshore Pharmaceuticals INC. | $22.00 | 2019 | |
| Astellas Pharma US INC | $18.57 | 2019 | |
| Lilly USA, LLC | $13.94 | 2019 | |
| Axonics, INC. | $13.00 | 2021 | |
| Phadia US INC. | $12.50 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.40 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.79 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.